SAB Biotherapeutics
Executives
View the org chart displaying its 15 main executives
Most searched biographies at SAB Biotherapeutics
- Samuel Reich, Executive Chairman of the Board and Chief Executive ...
- Scott Giberson, Director
- Katie Ellias, Director
Popular executive movements at SAB Biotherapeutics
- Samuel Reich, who was Executive Chairman of the Board, is promoted to Executive Chairman of the Board and Chief Executive Officer (posted on February 4 2024).
- Katie Ellias has joined the company as Director (posted on November 21 2023).
- Michael King has joined the company as Chief Financial Officer (posted on October 24 2023).
Click here to view some more movements at SAB Biotherapeutics
Create your alert
to follow the executive moves at SAB Biotherapeutics.
Biotechnology
SAB Biotherapeutics has 2,282 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
Popular contacts in Biotechnology
News
Press releases by SAB Biotherapeutics
- Presentations | SAB Biotherapeutics
- Events | SAB Biotherapeutics
- News Releases | SAB Biotherapeutics
- Big Cypress Acquisition Corp Announces Special Meeting of Stockholders to Approve Business Combination with SAB Biotherapeutics - SAb Biotherapeutics
Social media about SAB Biotherapeutics
- SAB Biotherapeutics on Wikipedia, Google News & Yahoo Finance
- SAB Biotherapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Katie Ellias 
Call SAB Biotherapeutics at +1 605...
